NADP-dependent glyceraldehyde-3-phosphate dehydrogenase

BE0002717ProteinStreptococcus mutans serotype c (strain ATCC 700610 / UA159)gapN

NADP-dependent glyceraldehyde-3-phosphate dehydrogenase (Streptococcus mutans serotype c (strain ATCC 700610 / UA159)) is a protein target in DrugBank. It is acted on by 2 drugs in DrugBank.

Gene name
gapN
UniProtKB entry
Q59931Swiss-Prot
Residues / weight
475 residues · 51,193 Da
Also known as
1.2.1.9 · Glyceraldehyde-3-phosphate dehydrogenase [NADP(+)] · Non-phosphorylating glyceraldehyde 3-phosphate dehydrogenase · Triosephosphate dehydrogenase

Resolves to

Protein
UniProtQ59931UniProt nameGAPN_STRMU
Gene
NCBI Gene1028095
Pharmacology
KEGGsmu:SMU_676
Structure
PDB1EUHPDB1QI1PDB1QI6
Drugs

What you can answer from here — as of September 07, 2019

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
2GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on NADP-dependent glyceraldehyde-3-phosphate dehydrogenase, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In